NEOPHORE LIMITED

Active Altrincham

Research and experimental development on biotechnology

10 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
N

NEOPHORE LIMITED

Research and experimental development on biotechnology

Founded 9 May 2017 Active Altrincham, United Kingdom 10 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 7 Jul 2025 Next due 31 Dec 2026 8 months remaining
Confirmation Submitted 12 May 2025 Next due 22 May 2026 25 days remaining
Net assets £9M £2M 2024 year on year
Total assets £11M £2M 2024 year on year
Total Liabilities £1M £359K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for NEOPHORE LIMITED (10762171), an active life sciences and medical technology company based in Altrincham, United Kingdom. Incorporated 9 May 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2017–2024)

Cash in Bank

£9.11M

Decreased by £1.99M (-18%)

Net Assets

£9.14M

Decreased by £2.00M (-18%)

Total Liabilities

£1.47M

Decreased by £359.15k (-20%)

Turnover

N/A

Employees

10

Debt Ratio

14%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 6
Grants 1

Investors (12)

Investor NameInvestor SinceParticipating Rounds
Investor 1Nov 2017Series A, Series B
Investor 2Nov 2017Seed
Investor 8Mar 2021Series B

Share Capital

Share Capital

Share allotments and capital structure

16 Allotments 2,612,649 Shares £40.22m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
21 Jun 202416,291£16.291£0.001
3 Apr 2024294,516£5.02m£17.05
5 Jan 2024563,591£9.61m£17.05
8 Dec 2022337,243£5.75m£17.05
31 Jan 2022576,062£9.36m£16.24

Officers

Officers

3 active
Status
Marianne BjordalDirectorNorwegianFrance496 Mar 2024Active
Oakwood Corporate Secretary LimitedCorporate-secretaryUnited KingdomUnknown9 May 2017Active
Robert Ian JamesDirectorBritishEngland618 Nov 2017Active

Shareholders

Shareholders (84)

Crt Pioneer Gp Limited (as Nominee For Crt Pioneer Fund Lp)
13.1%
369,560
Bristol-myers Squibb Company
10.4%
293,255

Persons with Significant Control

Persons with Significant Control (0)

0 Active 3 Ceased

Jeffrey James Roix

Ceased 8 Nov 2017

Ceased

Crt Pioneer Gp Limited

Ceased 5 Jan 2024

Ceased

Christopher John Torrance

Ceased 8 Nov 2017

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Oct 2025OfficersChange to director Dr Marianne Bjordal on 2025-10-01
7 Jul 2025AccountsAnnual accounts made up to 2025-03-31
12 May 2025Confirmation StatementConfirmation statement made on 2025-05-08 with updates
20 Jan 2025ResolutionResolutions
20 Jan 2025IncorporationMemorandum Articles
10 Oct 2025 Officers

Change to director Dr Marianne Bjordal on 2025-10-01

7 Jul 2025 Accounts

Annual accounts made up to 2025-03-31

12 May 2025 Confirmation Statement

Confirmation statement made on 2025-05-08 with updates

20 Jan 2025 Resolution

Resolutions

20 Jan 2025 Incorporation

Memorandum Articles

Recent Activity

Latest Activity

Change to director Dr Marianne Bjordal on 2025-10-01

6 months ago on 10 Oct 2025

Annual accounts made up to 2025-03-31

9 months ago on 7 Jul 2025

Confirmation statement made on 2025-05-08 with updates

11 months ago on 12 May 2025

Resolutions

1 years ago on 20 Jan 2025

Memorandum Articles

1 years ago on 20 Jan 2025